222 related articles for article (PubMed ID: 20634380)
1. Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
Sigal DS; Miller HJ; Schram ED; Saven A
Blood; 2010 Oct; 116(16):2884-96. PubMed ID: 20634380
[TBL] [Abstract][Full Text] [Related]
2. 2-Chlorodeoxyadenosine, a "novel" agent in the treatment of both lymphoid and myeloid malignancies.
Lauria F
Haematologica; 1992; 77(6):443-5. PubMed ID: 1363233
[No Abstract] [Full Text] [Related]
3. Cladribine in indolent non-Hodgkin's lymphoma.
Sigal DS; Saven A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):535-45. PubMed ID: 18402520
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
[TBL] [Abstract][Full Text] [Related]
5. The role of cladribine in the treatment of lymphoid malignancies.
Nelson MC; Hogan DK
Oncol Nurs Forum; 1995 Oct; 22(9):1395-400. PubMed ID: 8539180
[TBL] [Abstract][Full Text] [Related]
6. 2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
Saven A; Piro LD
Leuk Lymphoma; 1993; 10 Suppl():43-9. PubMed ID: 8097654
[No Abstract] [Full Text] [Related]
7. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
Greyz N; Saven A
Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
[TBL] [Abstract][Full Text] [Related]
8. [Cladribine].
Ogura M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
[TBL] [Abstract][Full Text] [Related]
9. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Rai KR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
[TBL] [Abstract][Full Text] [Related]
10. Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.
Robak T; Korycka A; Robak E
Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):23-38. PubMed ID: 18221024
[TBL] [Abstract][Full Text] [Related]
11. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
Pott-Hoeck C; Hiddemann W
Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
[TBL] [Abstract][Full Text] [Related]
12. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
[TBL] [Abstract][Full Text] [Related]
13. New prospects in the treatment of indolent lymphomas with purine analogues.
Cheson BD
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
[TBL] [Abstract][Full Text] [Related]
14. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Saven A; Piro LD
Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
[TBL] [Abstract][Full Text] [Related]
15. Ibrutinib in B lymphoid malignancies.
Smith MR
Expert Opin Pharmacother; 2015; 16(12):1879-87. PubMed ID: 26165513
[TBL] [Abstract][Full Text] [Related]
16. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
Beksaç M; Arat M; Idilman R
Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999
[No Abstract] [Full Text] [Related]
17. Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders.
Robak T; Wierzbowska A; Robak E
Rev Recent Clin Trials; 2006 Jan; 1(1):15-34. PubMed ID: 18393777
[TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Góra-Tybor J; Robak T
Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
[TBL] [Abstract][Full Text] [Related]
19. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
20. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
Polliack A
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():41-51. PubMed ID: 9570679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
